Clear cell papillary renal cell carcinoma: A chromosomal microarray analysis of two cases using a novel Molecular Inversion Probe (MIP) technology

Pathology Research and Practice

Volumn 210, Issue 12, 2014, Pages 1049-1053

  Alexiev, Borislav A ^a   Zou, Ying S ^a  

^a UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

Molecular Inversion Probe; Renal carcinoma

Indexed keywords

ANALYTICAL EQUIPMENT; ARTICLE; CASE REPORT; CHROMOSOME 10Q; CHROMOSOME 13Q; CHROMOSOME 8P; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHROMOSOME DUPLICATION; CHROMOSOME XP; CLEAR CELL PAPILLARY RENAL CELL CARCINOMA; FLUORESCENCE IN SITU HYBRIDIZATION; HETEROZYGOSITY LOSS; HISTOLOGY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MICROARRAY ANALYSIS; MOLECULAR INVERSION PROBE; MOLECULAR PROBE; PAPILLARY CARCINOMA; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; GENE DOSAGE; GENETICS; KIDNEY TUMOR; MUTATION; PATHOLOGY; PROCEDURES;

MOLECULAR PROBE;

CARCINOMA, RENAL CELL; GENE DOSAGE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KIDNEY NEOPLASMS; LOSS OF HETEROZYGOSITY; MICROARRAY ANALYSIS; MOLECULAR PROBES; MUTATION;

EID: 84940162648     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2014.10.001     Document Type: Article

References (15)

1. Adam J., Couturier J., Molinie V., Vieillefond A., Sibony M. Clear-cell papillary renal cell carcinoma: 24 cases of a distinct low-grade renal tumour and a comparative genomic hybridization array study of seven cases. Histopathology 2011, 58:1064-1071.
2. Alexiev B.A., Thomas C., Zou Y.S. Clear cell papillary renal cell carcinoma with angiomyomatous stroma: a histological, immunohistochemical, and fluorescence in situ hybridization study. Virchows Arch 2014, 464:709-716.
3. Chen M., Ye Y., Yang H., Tamboli P., Mtin S., Tannir N., Wood C., Gu J., Wu X. Genome-wide profiling of chromosomal alterations in renal cell carcinoma using highdensity single nucleotide polymorphism arrays. Int J Cancer 2009, 125:2342-2348.
4. Fisher K.E., Yin-Goen O., Alexis D., Sirintrapun J.S., Harrison W., Benjamin Isett R., Rossi M.R., Moreno C.S., Young A.N., Osunkoya A.O. Gene expression profiling of clear cell papillary renal cell carcinoma: comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma. Mod Pathol 2014, 27:222-230.
5. Gobbo S., Eble J.N., Grignon D.J., Martignoni G., MacLennan G.T., Shah R.B., Zhang S., Brunelli M., Cheng L. Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity. Am J Surg Pathol 2008, 32:1239-1245.
6. Lawrie C.H., Larrea E., Larrinaga G., Goicoechea I., Arestin M., Fernandez-Mercado M., Hes O., Cáceres F., Manterola L., López J.I. Targeted next-generation sequencing and non-coding RNA expression analysis of clear cell papillary renal cell carcinoma suggests distinct pathological mechanisms from other renal tumour subtypes. J Pathol 2014, 232:32-42.
7. Rao P., Monzon F., Jonasch E., Matin S.F., Tamboli P. Clear cell papillary renal cell carcinoma in patients with von Hippel-Lindau syndrome-clinicopathological features and comparative genomic analysis of 3 cases. Hum Pathol 2014, 45:1966-1972.
8. Rohan S.M., Xiao Y., Liang Y., Dudas M.E., Al-Ahmadie H.A., Fine S.W., Gopalan A., Reuter V.E., Rosenblum M.K., Russo P., Tickoo S.K. Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the vonHippel-Lindau gene and hypoxia-inducible factor pathway-related proteins. Mod Pathol 2011, 24:1207-1220.
9. Singh R.B., Amare P.S., Kadam Investigation of tumore suppressor genes apart fromVHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC). Urol Oncol 2013, 31:1333-1342.
10. Srigley J.R., Delahunt B., Eble J.N., Egevad L., Epstein J.I., Grignon D., Hes O., Moch H., Montironi R., Tickoo S.K., Zhou M., Argani P. ISUP Renal Tumor Panel. The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia. Am J Surg Pathol 2013, 37:1469-1489.
11. Sükösd F., Kuroda N., Beothe T., Kaur A.P., Kovacs G. Deletion of chromosome 3p14.3-p25 involving the VHL and FHIT genes in conventional renal cell carcinoma. Cancer Res 2003, 63:455-457.
12. Tickoo S.K., dePeralta-Venturina M.N., Harik L.R., Worcester H.D., Salama M.E., Young A.N., Moch H., Amin M.B. Spectrum of epithelial neoplasms in end-stage renal disease. An experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol 2006, 30:141-153.
13. Wang Y., Carlton V.E., Karlin-Neumann G., Sapolsky R., Zhang L., Moorhead M., Wang Z.C., Richardson A.L., Warren R., Walther A., Bondy M., Sahin A., Krahe R., Tuna M., Thompson P.A., Spellman P.T., Gray J.W., Mills G.B., Faham M. High quality copy number and genotype data from FFPE samples using Molecular Inversion Probe (MIP) microarrays. BMC Med Genom 2009, 2:8.
14. Wang Y., Cottman M., Schiffman J. Molecular inversion probes: a novel microarray technology and its application in cancer research. Cancer Genet 2012, 205:341-355.
15. Wolfe A., Dobin S.M., Grossmann P., Michal M., Donner L.R. Clonal trisomies 7, 10 and 12, normal 3p and absence of VHL gene mutation in a clear cell tubulopapillary carcinoma of the kidney. Virchows Arch 2011, 459:457-463.